Vaccination of C57BL/10 mice against cutaneous leishmaniasis. Use of purified gp63 encapsulated into niosomes surfactants vesicles: a novel approach.
Lezama-Dávila
C M
CM
Department of Immunology, University of Strathclyde, Glasgow, U.K.
D000818:Animals; D004337:Drug Carriers; D016773:Leishmaniasis, Cutaneous / Q000517:prevention & control*; D008666:Metalloendopeptidases; D051379:Mice; D008810:Mice, Inbred C57BL; D015800:Protozoan Proteins; D016052:Protozoan Vaccines / Q000008:administration & dosage*; D013501:Surface-Active Agents; D014611:Vaccination / Q000379:methods*
D004337:Drug Carriers; D015800:Protozoan Proteins; D016052:Protozoan Vaccines; D013501:Surface-Active Agents; D008666:Metalloendopeptidases; C055146:glycoprotein gp63, Leishmania